Dupuytrens Contracture Market Highlights:
TheDupuytrens Contracture Market insightsreport anticipates the industry to reach USD 5,900 Million by 2030 at 4.9% CAGR during the forecast period 2022-2030.
Dupuytren's contracture is a condition primarily of the fingers of the hand in which there is difficulty in articulating fingers due to formation of knots of tissue form under the skin which may worsen to a degree that fingers become permanently bent in a flexed position. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. Dupuytren's contracture has a higher rate in males over the age of 50. There is also a genetic propensity with Caucasians being affected more while it is rare among Asians and Africans. Dupuytren's contracture has a regress rate of approximately 10 % of patients. The annual incidence proportion of this disease was estimated at about 3 cases per 10,000 adults. The occurrence rate in the United States is about 5% of people, while Scandinavian nations has a higher rate of about 30% of men over 60 years old have the condition.
Needle aponeurotomy (NA) is the preferred surgical treatment of choice and used in the majority of patients. It is less invasive than the open hand surgery which is now reserved for the most severe conditions. The collagenase injection segment is however expected to grow the fastest due to minimum invasive nature and the lesser hospitalization stay.
The market drivers for Dupuytrens contracture market are increasing cardiac cases such as heart attack, other factors include cancer, kidney failure, end-stage lung cancer, hypothyroidism, rising screening and penetration of healthcare, growing awareness about cardiac diseases and growing income and healthcare expenditure etc. The market restraints are cost of Dupuytrens contracture surgery, complications and risk of the surgery, invasive nature of treatment etc.
Global Dupuytrens contracture Market Players
Key players mentioned in theDupuytrens Contracture Market outlookreport are Bristol-Meyers Squibb Co, Fresenius Kabi, Merck Company, Pfizer Inc., West-Ward Pharmaceuticals, Spear Pharmacueticals, Actiza Pharmaceutical Private Limited, Nantong Jinghua Pharmaceutical Co., Ltd., Endo International plc. Pfizer Inc., and others.
Regional Analysis
Europe account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the greater prevalence of Dupuytrens contracture in Europe drives the Dupuytrens contracture market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The highly developed healthcare system of the Scandavanian region coupled with high expenditure on healthcare, cruises the sale of Dupuytrens contracture treatment. Europe is led by countries such as Germany and France. Norway is expected to be the fastest growing market.
US is the second largest market in the world due to high income and healthcare penetration. The presence of large healthcare players in the US benefits the market coupled with the high public expenditure on healthcare which comes to be approximately 16 % of the GDP. Asia Pacific region is expected to grow at a slower rate with China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. The lower prevalence of Dupuytrens contracture in the Asian populations acts as a drag on the market.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East African market. The development of large hospitals such as the King Fahd hospital in Riyadh is driving the market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. Also the lower prevalence of Dupuytrens contracture in the Asian populations acts as a drag on the market.
Segmentation
The global Dupuytrens contracture market has been segmented on the basis of types, diagnosis, surgery, drugs, therapy and end users.
Based on type, the market has been segmented as type I, type II, type III.
Based on diagnosis, the market has been segmented as physical examination, x-ray and others.
Based on drug, the market has been segmented as steroids, collagenase injection, immune-modulators and others.
Based on therapy, the market has been segmented as radiation therapy, physiotherapy and others.
Based on the end user, the market has been segmented as hospitals clinics, academic and research and others.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
